We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · July 13, 2021

Perioperative Pharmacokinetic–Guided Factor VIII Concentrate Dosing in Haemophilia

The Lancet Haematology


Additional Info

The Lancet Haematology
Perioperative Pharmacokinetic-Guided Factor VIII Concentrate Dosing in Haemophilia (OPTI-CLOT trial): An Open-Label, Multicentre, Randomised, Controlled Trial
Lancet Haematol 2021 Jul 01;8(7)e492-e502, I van Moort, T Preijers, LH Bukkems, HCAM Hazendonk, JG van der Bom, BAP Laros-van Gorkom, EAM Beckers, L Nieuwenhuizen, FJM van der Meer, P Ypma, M Coppens, K Fijnvandraat, REG Schutgens, K Meijer, FWG Leebeek, RAA Mathôt, MH Cnossen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading